Page last updated: 2024-10-31

neostigmine and Diffuse Myofascial Pain Syndrome

neostigmine has been researched along with Diffuse Myofascial Pain Syndrome in 2 studies

Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
KABAT, H1
JONES, CW1
Voiculescu, V1
Călcăianu, G1
Stănescu, A1

Other Studies

2 other studies available for neostigmine and Diffuse Myofascial Pain Syndrome

ArticleYear
Studies on neuromuscular dysfunction; neostigmine therapy of acute and chronic cervical intramuscular fibrositis.
    Archives of physical medicine and rehabilitation, 1945, Volume: 26

    Topics: Disease; Fibromyalgia; Humans; Injections, Intramuscular; Neck; Neostigmine; Rheumatic Diseases

1945
Abnormal reflexes in the "stiff-man" syndrome.
    Revue roumaine de neurologie, 1970, Volume: 7, Issue:3

    Topics: Adrenocorticotropic Hormone; Chloral Hydrate; Chlorpromazine; Cortisone; Electromyography; Female; F

1970